Which patients with atopic eczema and psoriasis develop depression, anxiety and severe mental illness: is the evidence clear?

被引：1
|
作者：
von Kobyletzki, Laura [1 ]
机构：
[1] Lund Univ, Orebro Univ, Skane Univ Hosp, Ctr Clin Res,Dept Occupat & Environm Dermatol, Orebro, Sweden
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷 / 04期
关键词：
D O I：
10.1093/bjd/ljad009
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：458 / 459
页数：2
相关论文
共 42 条
  • [41] Improvements in anxiety and depression among patients with moderate to severe plaque psoriasis treated with certolizumab pegol: Three-year results from 2 phase 3 trials (CIMPASI-1 and CIMPASI-2)
    Armstrong, April
    McBride, Sandra
    Spelman, Lynda
    Fernandez-Penas, Pablo
    Rich, Phoebe
    Martin, George
    Tilt, Nicola
    Pinto, Jose M. Lopez
    Popova, Christina
    Hellot, Scarlett
    Wilsmann-Theis, Dagmar
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB175 - AB175
  • [42] Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial
    Langley, Richard G.
    Feldman, Steven R.
    Han, Chenglong
    Schenkel, Brad
    Szapary, Philippe
    Hsu, Ming-Chun
    Ortonne, Jean-Paul
    Gordon, Kenneth B.
    Kimball, Alexa B.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 63 (03) : 457 - 465
12345